Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors
Article in Lung Cancer (May 2016)
The most recent citing publications are shown below. View all 7 publications that cite this research output on Dimensions.
Phase II Clinical Trial of Gefitinib for the Treatment of Chemonaïve Patients with Advanced Non-small Cell Lung Cancer with Poor Performance Status
Article in Clinical Medicine Insights Oncology (January 2014)
Maintenance therapy of gefitinib for non-small-cell lung cancer after first-line chemotherapy regardless of epidermal growth factor receptor mutation: a review in Chinese patients
Article in Current Medical Research and Opinion (October 2012)